Latigo Biotherapeutics, Inc. · NASDAQ:LTGO
Ra Capital Management, L.P. reported a 8.40% stake in Latigo Biotherapeutics, Inc. (Schedule 13G)
Event Aug 10, 2026 · Filed Aug 17, 2026
Ra Capital Management, L.P. reported a 8.40% stake in Latigo Biotherapeutics, Inc., 5,295,690 shares, as a passive investor on Aug 10, 2026. Filed Aug 17, 2026 (Schedule 13G).
- Stake
- 8.40%
- Shares
- 5,295,690
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 8.40% | 5,295,690 |
| Peter Kolchinsky | 8.40% | 5,295,690 |
| Rajeev Shah | 8.40% | 5,295,690 |
| RA Capital Healthcare Fund, L.P. | 8.40% | 5,295,690 |
Source
Related
- Latigo Biotherapeutics, Inc.
- Ra Capital Management, L.P.
- Latigo Biotherapeutics, Inc. shareholders
- Schedule 13G · AI Biotechnology LLC · Aug 18, 2026
- Schedule 13D · James B. Tananbaum · Aug 17, 2026
- Schedule 13D · James B. Tananbaum · Aug 17, 2026
- Schedule 13G · Deep Track Capital, LP · Aug 13, 2026
- Form 4 · 5AM Partners VI, LLC · Aug 12, 2026